-
Comparison of AI-Enhanced Tools for Automating Scientific Literature Reviews
Mar 10, 2025, 14:00 PM -
Quantifying Spillover Impacts: Effect of Novel Therapies for IgA Nephropathy on Patients Awaiting Kidney Transplant
Mar 10, 2025, 14:00 PM -
The Impact of Prior Choice for Between-Study Heterogeneity in Network Meta-Analysis on Model Conclusions
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Population-Based Risk Assessment and Hereditary Cancer Genetic Testing in Primary Care
Mar 10, 2025, 14:00 PM -
Disease and Economic Burden of Dengue in Colombia, 2018-2022
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization of Patients with Chronic Lymphocytic Leukemia Treated with Fixed Duration Therapy in a First-Line Setting in Alberta, Canada
Mar 10, 2025, 14:00 PM -
Characterizing the Burden and Drivers of Healthcare Utilization and Spending for Epilepsy and Seizures in the U.S., 2016-2022
Mar 10, 2025, 14:00 PM -
Bridging Racial Disparities in Aspirin Therapy for Preeclampsia Prevention Using Virtual Maternity Care
Mar 10, 2025, 14:00 PM -
Impact of Single-Patient use Electrocardiogram Monitoring in the Cost of Care and Infection Prevention of CABG Surgery Patients in the USA
Mar 10, 2025, 14:00 PM -
Annual Direct Medical Costs with Beta-Thalassemia in the Brazilian Public Healthcare System (SUS)
Mar 10, 2025, 14:00 PM -
Augmenting Race and Ethnicity in a Real-World Oncology Cohort Using the Bayesian Improved Surname Geocoding Methodology
Mar 10, 2025, 14:00 PM -
The Cost-effectiveness Analysis of Gene Therapy for Severe Hemophilia B Patients in China: A Microsimulation Experiment Study
Mar 10, 2025, 14:00 PM -
Expected vs. Observed Mortality Rates, Expressed As Number Needed to Treat, From a Phase 3 Clinical Trial Program of Patients With Hyperphagia and Prader-Willi Syndrome Treated With Diazoxide Choline Extended Release (DCCR)
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Protocol Biopsy and Non-Invasive Biomarkers for Monitoring Transplant Rejection Within One-Year Post-Kidney Transplants
Mar 10, 2025, 14:00 PM -
Evaluating the ICER Special Report in the Context of Medicare Drug Price Negotiations: Implications for Manufacturer Pricing and Evidence Strategies
Mar 10, 2025, 14:00 PM -
Estimating the Burden of Illness and Healthcare Costs Among Incident Intermittent Catheter Users: A Comparison of Neurogenic and Non-Neurogenic Bladder Cohorts in the US
Mar 10, 2025, 14:00 PM -
Economic Burden of Rheumatoid Arthritis in Low- and Middle-Income Countries: Systematic Review
Mar 10, 2025, 14:00 PM -
Effectiveness of Activity Criteria in Stabilizing Patient Cohorts in Open Claims Data for Healthcare Outcomes Research
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of First-Line Tremelimumab Plus Durvalumab Versus Sorafenib in Unresectable Hepatocellular Carcinoma
Mar 10, 2025, 14:00 PM -
Prognostic or Predictive Factors in Biliary Tract Cancer: A Systematic Literature Review
Mar 10, 2025, 14:00 PM
